CGC   17.26 (-0.35%)
BABA   256.08 (+0.93%)
CGC   17.26 (-0.35%)
BABA   256.08 (+0.93%)
CGC   17.26 (-0.35%)
BABA   256.08 (+0.93%)
CGC   17.26 (-0.35%)
BABA   256.08 (+0.93%)
Log in

LON:KMKKromek Group Share Price, Forecast & News

GBX 15.25
+0.62 (+4.24 %)
(As of 08/14/2020 08:42 AM ET)
Add
Compare
Today's Range
14.74
Now: GBX 15.25
15.29
50-Day Range
13.88
MA: GBX 16.80
19.25
52-Week Range
0.17
Now: GBX 15.25
28
Volume515,234 shs
Average Volume290,238 shs
Market Capitalization£52.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for applications in the medical, nuclear, and security screening markets worldwide. Its solutions provide high resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and gamma-ray CZT detectors. In addition, it offers medical imaging products, including CZT gamma cameras for SPECT imaging, CZT surgical gamma probes, CZT bone mineral densitometry, and photon-counting spectral CT. Further, the company provides security products, such as D3S wearable RIID gamma neutron detectors; liquid explosive detection algorithm for type c systems; Identifier liquid explosive detectors; and X-ray scalable linear arrays. Additionally, it engages in scientific research and development activities. Kromek Group plc was incorporated in 2003 and is headquartered in Sedgefield, the United Kingdom.
Read More
Kromek Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1740-626060

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£16.17 million
Cash FlowGBX 3.63 per share
Book ValueGBX 17.10 per share

Profitability

Miscellaneous

Employees100
Market Cap£52.55 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 15.25
+0.62 (+4.24 %)
(As of 08/14/2020 08:42 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KMK News and Ratings via Email

Sign-up to receive the latest news and ratings for KMK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Kromek Group (LON:KMK) Frequently Asked Questions

How has Kromek Group's stock been impacted by Coronavirus?

Kromek Group's stock was trading at GBX 18 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KMK stock has decreased by 15.3% and is now trading at GBX 15.25.
View which stocks have been most impacted by COVID-19
.

How were Kromek Group's earnings last quarter?

Kromek Group PLC (LON:KMK) issued its quarterly earnings data on Wednesday, December, 11th. The company reported ($0.70) earnings per share for the quarter.
View Kromek Group's earnings history
.

Has Kromek Group been receiving favorable news coverage?

Headlines about KMK stock have trended positive on Friday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Kromek Group earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Kromek Group
.

Who are some of Kromek Group's key competitors?

What other stocks do shareholders of Kromek Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kromek Group investors own include Eden Research (EDEN), Alkane Energy (ALK), Surgical Innovations Group (SUN), Carclo (CAR), Baozun (BZUN), Bahamas Petroleum (BPC), Bonmarche (BON), Bristol-Myers Squibb (BMY), BK CHINA LTD/ADR (BACHY) and Alibaba Group (BABA).

Who are Kromek Group's key executives?

Kromek Group's management team includes the following people:
  • Dr. Arnab Basu, CEO & Exec. Director (Age 46)
  • Mr. Derek Bulmer, CFO, Company Sec. & Exec. Director (Age 53)
  • Mr. Berry Beumer, Chief Operating Officer
  • Mr. Ian Radley, Chief Technical Officer (Age 62)
  • Prof. Brian Keith Tanner MA, DPhil, CPhys, FInstP, FRSA, Advisor (Age 71)

What is Kromek Group's stock symbol?

Kromek Group trades on the London Stock Exchange (LON) under the ticker symbol "KMK."

How do I buy shares of Kromek Group?

Shares of KMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Kromek Group's stock price today?

One share of KMK stock can currently be purchased for approximately GBX 15.25.

How big of a company is Kromek Group?

Kromek Group has a market capitalization of £52.55 million and generates £16.17 million in revenue each year. Kromek Group employs 100 workers across the globe.

What is Kromek Group's official website?

The official website for Kromek Group is www.kromek.com.

How can I contact Kromek Group?

Kromek Group's mailing address is Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom. The company can be reached via phone at +44-1740-626060.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.